You are in:Home/Publications/Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Infection among Hemodialysis Patients

Dr. mahmoud.hamada :: Publications:

Title:
Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Infection among Hemodialysis Patients
Authors: M Hamada, E Gamal
Year: 2017
Keywords: Not Available
Journal: The Journal of Vascular Access
Volume: 18
Issue: 6
Pages: 498-502
Publisher: Sage
Local/International: International
Paper Link:
Full paper Not Available
Supplementary materials Not Available
Abstract:

INTRODUCTION: Catheter-related bloodstream infection (CRBSI) is a frequent complication among hemodialysis patients who usually are presented with nonspecific signs such as fever, rigors, and hypotension. Blood culture will take up to 5 days and antimicrobials will be started. Procalcitonin (PCT) is a valid marker in sepsis. Our goal in this study is to evaluate its usefulness as a diagnostic marker in detecting CRBSI among hemodialysis patients who present with suspected CRBSI. PATIENTS AND METHODS: Thirty-one hemodialysis patients with suspected CRBSI were enrolled in this study. PCT level was measured at the time of presentation. Patients were divided into two groups according to blood culture results: positive and negative groups. PCT level and other markers for inflammation: white blood cell count (WBC), C-reactive protein (CRP), and ferritin were compared between the two groups. Statistical analysis of variables was performed using the t-test or Mann-Whitney test together with Spearman correlation test. RESULTS: Thirty-one patients had a median age 44.7 ± 2.1 years. They comprised 16 males (52%) and 15 females (48%). Sixteen patients had a positive blood culture result while in 15 it was negative. PCT level was significantly higher in the positive blood culture group (40.0 ± -21.9) (95% confidence interval [CI] 28.4-51.8) while its level was 1.1 ± 1 (95% CI 0.54-1.8) in the negative blood culture group [t(15) = -7, p

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus